Massachusetts Financial Services Co. MA Grows Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Massachusetts Financial Services Co. MA increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 9.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 478,104 shares of the company's stock after purchasing an additional 39,759 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.55% of HealthEquity worth $42,250,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of HQY. Ameritas Investment Partners Inc. lifted its stake in HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock valued at $3,248,000 after buying an additional 88 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in HealthEquity by 0.6% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock valued at $1,850,000 after acquiring an additional 106 shares during the period. Hancock Whitney Corp raised its holdings in shares of HealthEquity by 1.0% during the fourth quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock valued at $1,279,000 after buying an additional 133 shares during the last quarter. Xponance Inc. raised its holdings in HealthEquity by 1.1% during the first quarter. Xponance Inc. now owns 12,412 shares of the company's stock worth $1,097,000 after purchasing an additional 136 shares in the last quarter. Finally, Level Four Advisory Services LLC grew its position in HealthEquity by 5.3% during the 4th quarter. Level Four Advisory Services LLC now owns 2,736 shares of the company's stock worth $263,000 after purchasing an additional 138 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In related news, Director Jon Kessler sold 134,183 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the transaction, the director owned 253,510 shares of the company's stock, valued at approximately $28,413,400.80. This represents a 34.61% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 291,744 shares of company stock valued at $32,705,007. Company insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. JMP Securities increased their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. Bank of America boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Royal Bank Of Canada upped their target price on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. Finally, Raymond James Financial reissued a "strong-buy" rating and issued a $120.00 price target (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $118.55.

HealthEquity Stock Up 2.5%

NASDAQ HQY opened at $100.12 on Friday. The company has a market capitalization of $8.66 billion, a price-to-earnings ratio of 73.08, a PEG ratio of 1.51 and a beta of 0.49. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The stock's 50 day moving average is $101.51 and its two-hundred day moving average is $98.45.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. The business had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter last year, the company posted $0.80 earnings per share. Equities analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.